KraneShares MSCI All China Health Care Index ETF (KURE)
15.80
+0.54 (3.54%)
NYSE · Last Trade: May 3rd, 3:56 AM EDT
Detailed Quote
Previous Close | 15.26 |
---|---|
Open | 15.72 |
Day's Range | 15.59 - 15.80 |
52 Week Range | 12.91 - 20.51 |
Volume | 2,282 |
Market Cap | 845.30K |
Dividend & Yield | 0.1840 (1.16%) |
1 Month Average Volume | 20,152 |
Chart
News & Press Releases
These ETFs beat the S&P 500 in April 2025’s turbulent market. Learn how TOLZ, VIXY, and KURE can help stabilize your investment strategy.
Via MarketBeat · April 15, 2025
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via Benzinga · April 11, 2025

China's NPC meeting has sparked optimism in the market, with Chinese stocks and bonds rallying. Investors are hopeful for growth targets but remain skeptical.
Via Benzinga · March 7, 2025
China Stocks Look Set For A Rebound, Morgan Stanley Quant Strategists Saybenzinga.com
Investors in mainland China are rapidly unwinding their stock-index hedges, in an indication that a possible end to Chengdu’s lockdown and policies to stabilize the yuan will lead to a near-term market rally, reported
Via Benzinga · September 13, 2022